Pixelgen Technologies closes $15.5M oversubscribed Series B round led by Flat Capital to accelerate global expansion and commercialization of its Proxiome Kit.
PRIVATEAug 20, 2026•about 4 hours ago
Amount Raised
$15.5 Million
Round Type
Series B
StockholmBiotechnology
Investors
Navigare VenturesIndustrifondenFlat Capital
Description
Pixelgen Technologies has successfully closed a $15.5 million Series B financing aimed at accelerating their global commercialization efforts. This round was oversubscribed and led by new investor Flat Capital, with support from existing investors Industrifonden and Navigare Ventures. The funds will be used to expand the company's presence in key markets and grow their team and product portfolio. Pixelgen's Proxiome Kit offers a groundbreaking approach to mapping molecular cell architecture.
Company Information
Company
Pixelgen Technologies
Location
Stockholm, Stockholm County, Sweden
About
Pixelgen Technologies AB was founded in 2020 by a team of passionate, experienced innovators and entrepreneurs with a vision to bring a new spatial understanding to biology by mapping cell surface proteins and their spatial inter-relationships. The company has developed Molecular Pixelation, a DNA-based visualization technology for analyzing cell surface proteins, to gain novel insights into cellular activity that will advance better medicines and diagnostics.
Don't miss Pixelgen Technologies's next move
Get an email the moment Pixelgen Technologies raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Predictive Intelligence
Strategic
ML-powered predictions for Pixelgen Technologies's next move